Our results identified 1) somatic mutations in MYO18B, TRIM37, and IL7R as possible targetable drivers of oncogenesis, 2) a loss in copy number of chromosome 10q in primary tumor and lung metastasis samples, and 3) a high frequency of large-scale deletions and breakend point integrations into chromosome 2. Here, IL7R is linked to neoplasm.